Trial intelligence / Profile preview

Dexamethasone Palmitate vs Dexamethasone Sodium Phosphate for Chronic Postoperative Pain in Minimally Invasive Cardiac Surgery

NCT05920967Completed

Sponsor
Xijing Hospital
Start
Jul 2023
Primary completion
Sep 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of dexamethasone in chronic post-surgical pain (CPSP) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Incidence of chronic postoperative pain at 3 months. Started Jul 2023; status: completed.

02

Drugs

dexamethasone
03

Conditions

chronic post-surgical pain (CPSP)

Beyond the preview

Go deeper on NCT05920967.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05920967.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call